• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BARD PERIPHERAL VASCULAR, INC. SIMON NITINOL FILTER SYSTEM; VENA CAVA FILTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BARD PERIPHERAL VASCULAR, INC. SIMON NITINOL FILTER SYSTEM; VENA CAVA FILTER Back to Search Results
Model Number 2220J
Device Problem Obstruction of Flow (2423)
Patient Problems Pulmonary Embolism (1498); Thrombosis/Thrombus (4440)
Event Date 09/05/2016
Event Type  Injury  
Manufacturer Narrative
Manufacturing review: a device history record review could not be performed as the lot number is unknown.Investigation summary: the device was not returned for evaluation.Medical records were provided and reviewed.Approximately, one month twenty-five days of post deployment, computed tomography of chest with contrast revealed a small pulmonary embolism was identified in the right mainstem branches and leads to the right lower lobe.This embolus was largest in size on prior exam and may be residual emboli or possible new embolus.Vq scan revealed a new onset of right-side pulmonary embolism.There was a thrombus above the filter.Around, three months later, computed tomography of chest with contrast revealed possible for pulmonary embolism in the right lower lobar branch of the right pulmonary artery and possible in the posterior segmental branches of the left lower lobe.On the next day, computed tomography of chest showed and not clear if the pulmonary embolism was new or old.Around one year and three months later, chest x-ray revealed nonocclusive pulmonary embolus in the left lower lobe.On the same day, computed tomography of chest with contrast revealed intraluminal thrombus was identified in the pulmonary artery, extended to the left lower lobe.The filter was occluded.Around, one month later, computed tomography of chest with contrast revealed there are filling defects in the sub segmental and segmental pulmonary arteries of the left upper lobe and left lower lobe.Small filling defect in sub segmental pulmonary artery in the right lower lobe.After, eighteen days, computed tomography of chest with contrast revealed the pulmonary emboli identified on prior exam was no longer identified.A tiny residual thrombus was identified in an arterial branch of the left lower lobe.Therefore, the investigation is confirmed for the occlusion of the inferior vena cava (ivc).Additionally, it can be confirmed that the patient experienced pe post deployment and thrombus above the filter post deployment.However, the relationship to the filter is unknown.Based on the available information, the definitive root cause is unknown.Labeling review: a review of product labeling documents (e.G.Procedural instructions, indications, warnings, precautions, cautions, possible complications, contraindications, and unit label) showed that the product labeling is adequate.
 
Event Description
It was reported through the litigation process that a vena cava filter was placed in a patient after being diagnosed with deep vein thrombosis and pulmonary embolism.At some time post filter deployment, it was alleged that the filter occluded.The device has not been removed and there were no reported attempts made to retrieve the filter.The patient reportedly diagnosed with pulmonary embolism and experienced thrombus above the filter; however, the current status of the patient is unknown.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SIMON NITINOL FILTER SYSTEM
Type of Device
VENA CAVA FILTER
Manufacturer (Section D)
BARD PERIPHERAL VASCULAR, INC.
1625 w 3rd st.
tempe AZ 85281
Manufacturer (Section G)
C.R. BARD, INC. (GFO)
289 bay road
queensbury NY 12804
Manufacturer Contact
judith ludwig
1415 w. 3rd street
tempe, AZ 85281
4803032689
MDR Report Key11981712
MDR Text Key255617222
Report Number2020394-2021-80500
Device Sequence Number1
Product Code DTK
UDI-Device Identifier00801741040917
UDI-Public(01)00801741040917
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K970099
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,health professional
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 06/11/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/11/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number2220J
Device Catalogue Number2220J
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Date Manufacturer Received05/26/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
GABAPENTIN, REGLAN, PANTOPRAZOLE, CLONIDINE; LOVENOX, METOPROLOL, RAMIPRIL, PROTONIX; WARFARIN
Patient Outcome(s) Life Threatening; Other;
Patient Age37 YR
Patient Weight122
-
-